Human infection with G12 rotaviruses, Germany.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 2819891)

Published in Emerg Infect Dis on September 01, 2009

Authors

Corinna Pietsch1, Uwe G Liebert

Author Affiliations

1: Institute of Virology, Leipzig University, Leipzig, Germany. corinna.pietsch@medizin.uni-leipzig.de

Articles cited by this

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol (2007) 168.76

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49

Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93

Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol (2004) 5.20

Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77

Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12

Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. J Virol (2006) 1.61

Cloning of noncultivatable human rotavirus by single primer amplification. J Virol (1992) 1.48

Coupling of rotavirus genome replication and capsid assembly. Adv Virus Res (2007) 1.14

Viral determinants of rotavirus pathogenicity in pigs: production of reassortants by asynchronous coinfection. J Virol (1997) 0.89

Articles by these authors

A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Vaccine (2011) 0.91

Rubella virus-induced superinfection exclusion studied in cells with persisting replicons. J Gen Virol (2007) 0.89

Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a. Liver Int (2004) 0.85

Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe. PLoS One (2013) 0.82

Complex cancer gene therapy in mice melanoma. Langenbecks Arch Surg (2002) 0.80

Limited increase in primary HIV-1C drug resistance mutations in treatment naïve individuals in Ethiopia. J Med Virol (2015) 0.79

Childhood case of progressive multifocal leukoencephalopathy with improved clinical outcome. J Child Neurol (2005) 0.79

Particle-mediated cytokine gene therapy leads to antitumor and antimetastatic effects in mouse carcinoma models. Cancer Biother Radiopharm (2006) 0.78

Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection. Eur J Gastroenterol Hepatol (2013) 0.77

Adenoid squamous carcinoma (pseudoangiosarcomatous carcinoma) of the vulva: a rare but highly aggressive variant of squamous cell carcinoma-report of a case and review of the literature. Int J Gynecol Pathol (2008) 0.77

Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B. PLoS One (2013) 0.76

Experimental measles encephalitis in Lewis rats: dissemination of infected neuronal cell subtypes. J Neurovirol (2013) 0.75